Sign in to view content

Predicting Long-term Response to Ranibizumab After Three Injections in Patients With Age-Related Macular Degeneration

Paul Hahn, MD, PhD, FASRS

Video
Published 2020

Related

Prophylaxis Intravitreal Aflibercept Against Conversion to Neovascular AMD in High-Risk Eyes (PRO-CON): 24-Month Results
Jeffrey S. Heier, MD
Annual Meeting Talks
2019
AI-Based Spatiotemporal Observations of Retinal Fluid Dynamics Using the Notal Vision Home OCT
Anat Loewenstein, MD
Updates from the Field
2022
Safety Results of ONS-5010, an Ophthalmic Bevacizumab, in Treated Eyes of Patients With Wet AMD, DME, and BRVO
Suber S. Huang, MD, MBA, FASRS
Annual Meeting Talks
2021

Category: AMD-Neovascular

See more